Company Filing History:
3 out of 3 
3 out of 3 Years Active: 2024-2025
Title: Man Chen: Innovator in Tumor Detection Technologies
Introduction
Man Chen is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical diagnostics, particularly in the detection of tumors. With a total of two patents to his name, his work focuses on innovative reagent compositions that enhance the accuracy of tumor detection.
Latest Patents
Man Chen's latest patents include a reagent composition for the detection of non-hematopoietic tumors. This invention provides a comprehensive reagent composition that includes three sets of antibodies, facilitating flow cytometry screening and diagnosis. The first set comprises antibodies such as anti-CD9, anti-GD2, and anti-CD3, while the second set includes anti-HLA-ABC and anti-CD38 antibodies. The third set features anti-cytoplasmic cytokeratin antibodies. This innovative reagent composition is designed for effective diagnosis and follow-up detection of non-hematopoietic tumors.
Another notable patent by Man Chen is a detection reagent and therapeutic target for B cell tumors after targeted therapy. This invention also consists of three groups of antibodies, including anti-CD38, anti-CD10, and anti-CD19 antibodies, among others. The reagent composition is intended for the detection of B-lymphocyte tumors using flow cytometry, showcasing his commitment to advancing cancer diagnostics.
Career Highlights
Throughout his career, Man Chen has worked with reputable organizations such as Synarc Research Laboratory and Hebei Yanda Ludaopei Hospital. His experience in these institutions has allowed him to develop and refine his innovative approaches to tumor detection.
Collaborations
Man Chen has collaborated with notable colleagues, including Hui Wang and Aixian Wang, who have contributed to his research endeavors. Their combined expertise has furthered the development of effective diagnostic tools in the medical field.
Conclusion
Man Chen's contributions to tumor detection technologies highlight his role as an influential inventor in the medical diagnostics arena. His innovative patents and collaborative efforts continue to pave the way for advancements in cancer detection and treatment.